Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enamel hydroxyapatite is the primary mineral component of tooth enamel, accounting for approximately 97% of its composition. It provides structural integrity to teeth but can dissolve under acidic conditions, leading to dental caries. It's a target for remineralization therapies and is used as an active ingredient in modern toothpaste. Unlike pure hydroxyapatite, enamel hydroxyapatite incorporates various ionic substitutions, affecting its properties and reactivity.
Hydroxyapatite toothpaste deposits mineral ions directly into demineralized enamel, filling microscopic gaps and promoting remineralization. Fluoride promotes remineralization by forming fluorapatite, a more acid-resistant mineral.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enamel Hydroxyapatite.